Canada Urinalysis Market (2024-2029)
The Canada Urinalysis Market was valued at $147 Million in 2024 and projected to reach to $211.7 Million by 2029, representing a compound annual growth rate of 7.6%. Canada's urinalysis market is positioned for steady expansion driven by demographic and epidemiological factors unique to the country.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Canada Urinalysis Market Trends and Insights
- This represents a compound annual growth rate of 7.6%, reflecting increasing demand for diagnostic testing across Canadian healthcare facilities.
- Canada's aging population and rising prevalence of chronic diseases are driving adoption of urinalysis testing in both clinical and point-of-care settings. The Canadian urinalysis market benefits from advanced healthcare infrastructure and strong regulatory frameworks that support diagnostic innovation.
- Canada's emphasis on preventive healthcare and early disease detection is accelerating market expansion through 2029.
- Investment in laboratory automation and digital health integration is positioning Canada as a key market within North America's broader urinalysis sector..
Key Market Statistics
- CAGR (2024-2029) 7.6% CAGR
- Market Size, 2024 ~USD 147 Million
- Forecast, 2029 ~USD 211.7 Million
- Country Canada
Canada Urinalysis Market Overview
Market Size & Growth :
Canada's urinalysis market is valued at $147.0 million in 2024, with a projected CAGR of 7.6% through 2029, reaching $211.7 million by forecast end.
Aging Population Driver :
Canada's demographic shift toward an older population is significantly increasing demand for diagnostic testing, as seniors require more frequent urinalysis screening for chronic disease management.
Chronic Disease Prevalence :
Rising incidence of diabetes, hypertension, and kidney disease across Canadian provinces is driving healthcare providers to adopt urinalysis testing as a standard diagnostic protocol.
Healthcare Infrastructure Expansion :
Investment in Canadian diagnostic laboratories and point-of-care testing facilities is expanding urinalysis accessibility across urban and rural healthcare settings.
Canada Urinalysis Market Dynamics
- The aging Baby Boomer population combined with increasing prevalence of chronic diseases such as diabetes and chronic kidney disease is creating sustained demand for routine diagnostic testing across provincial healthcare systems.
- Canadian healthcare providers are increasingly integrating urinalysis into preventive care protocols, supporting market growth. Looking ahead to 2029, the market will benefit from technological advancements in automated urinalysis systems and growing adoption of integrated laboratory information systems across Canadian hospitals and clinics.
- Provincial health authorities' focus on early disease detection and preventive medicine will further accelerate market penetration, particularly in primary care settings and community health centers across Canada..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- Canada's urinalysis market will grow from $147.0M (2024) to $211.7M (2029) at a 7.6% CAGR
- Canada's aging demographic and chronic disease prevalence are primary growth catalysts for urinalysis demand
- Canada's advanced healthcare infrastructure supports adoption of automated and point-of-care urinalysis solutions
- Digital health integration and laboratory automation are key trends shaping Canada's urinalysis market evolution
Urinalysis Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | HOSPITALS & CLINICS (End User) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 9.6% from 2024 to 2029 |
| Largest Segment | CONSUMABLES (Product) |
| Market Size Base Year (Billions) | ~USD 4.3 (2024) |
| Revenue Forecast (Billions) | ~USD 6.8 (2029) |
| Segments Covered | Product, Type, Test Type, Application, End User |
Canada Urinalysis Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product
- Consumables
- Instruments
By Type
- Automated Urine Analyzers
- Biochemical Urine Analyzers
- Brazil
- Diabetes
- Dipsticks
- Disposables
- Flow Cytometry Analyzers
- Integrated Urine Analyzers
- Kidney Diseases
- Laboratory Tests
- Liver Diseases
- Mexico
- Microscopy Analyzers
- Other Disease Screening Applications
- Poc Tests
- Point-Of-Care Urine Analyzers
- Pregnancy & Fertility Kits
- Reagents
- Rest Of Latam
- Sediment Urine Analyzers
- Semi-Automated Urine Analyzers
- Urinary Tract Infections
By Test Type
- Biochemical Tests
- Pregnancy & Fertility Tests
- Sediment Urinalysis
By Application
- Disease Screening
- Pregnancy & Fertility Testing
By End User
- Diagnostic Laboratories
- Home Care Settings
- Hospitals & Clinics
- Research Laboratories & Institutes
CANADA: URINALYSIS MARKET, BY END USER, 2022–2029
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| DIAGNOSTIC LABORATORIES | 50.1 | 51.4 | 53.3 | 55.8 | 58.8 | 62.6 | 67.3 | 73.2 | 6.5 |
| HOME CARE SETTINGS | 34.6 | 35.6 | 36.9 | 38.7 | 40.8 | 43.5 | 46.9 | 51.1 | 6.7 |
| HOSPITALS & CLINICS | 41.8 | 44.1 | 47.1 | 50.7 | 54.9 | 60.3 | 66.8 | 74.9 | 9.7 |
| RESEARCH LABORATORIES & INSTITUTES | 9.3 | 9.4 | 9.7 | 10 | 10.4 | 11 | 11.7 | 12.6 | 5.4 |
| TOTAL | 135.8 | 140.5 | 147 | 155.1 | 164.9 | 177.3 | 192.7 | 211.7 | 7.6 |
Target Audience
- Diagnostic Equipment Manufacturers : Need Canada-specific market sizing and growth projections to develop localized product strategies, establish distribution networks, and identify procurement opportunities with Canadian healthcare facilities.
- Laboratory Service Providers : Require detailed market insights to assess expansion potential across Canadian provinces, understand competitive dynamics, and optimize service offerings for provincial health authorities.
- Healthcare Investors & PE Firms : Seek comprehensive Canada market data to evaluate investment opportunities in diagnostic testing companies, laboratory networks, and point-of-care testing providers operating in Canada.
- Hospital & Clinic Administrators : Need market intelligence to justify capital expenditures for urinalysis equipment, benchmark testing volumes against Canadian peers, and plan diagnostic service expansion.
- Healthcare Consultants & Advisors : Require Canada-specific market research to support client advisory work, feasibility studies, and strategic recommendations for diagnostic service providers and healthcare organizations.
Reasons to Buy this Report
- Market Size & Forecast Data : Access precise valuation of Canada's urinalysis market ($147.0M in 2024) with detailed 5-year forecasts to support strategic planning and investment decisions specific to the Canadian healthcare sector.
- Growth Driver Analysis : Understand the unique demographic and epidemiological factors driving Canada's 7.6% CAGR, including aging population trends and chronic disease prevalence across provinces.
- Competitive Landscape Intelligence : Identify key players and market dynamics specific to Canada's urinalysis sector, enabling informed competitive positioning and partnership strategies in the Canadian market.
- Regional Healthcare Insights : Gain insights into provincial healthcare system adoption patterns, regulatory environment, and reimbursement structures that influence urinalysis testing demand across Canada.
- Investment & Expansion Planning : Leverage Canada-specific market data to evaluate expansion opportunities, facility investments, and product development priorities aligned with Canadian healthcare provider needs.
Frequently asked questions
What is the current size of Canada's urinalysis market?
Canada's urinalysis market was valued at $147.0 million in 2024 and is expected to reach $211.7 million by 2029.
What is the projected growth rate for Canada's urinalysis market?
Canada's urinalysis market is projected to grow at a compound annual growth rate (CAGR) of 7.6% from 2024 to 2029.
What factors are driving growth in Canada's urinalysis market?
Key drivers include Canada's aging population, rising prevalence of chronic diseases, advanced healthcare infrastructure, and increasing adoption of point-of-care and automated testing solutions.
How is Canada's urinalysis market positioned within North America?
Canada represents a significant segment of the North American urinalysis market, benefiting from strong regulatory frameworks, preventive healthcare emphasis, and digital health integration initiatives.
What technological trends are influencing Canada's urinalysis market?
Laboratory automation, digital health integration, point-of-care testing devices, and data analytics are key technological trends reshaping Canada's urinalysis market landscape.
RESEARCH METHODOLOGY
The objective of this study is to analyze the key market dynamics, including drivers, opportunities, constraints, challenges, and strategies employed by key players. Developments within companies, such as acquisitions, product launches, expansions, agreements, and partnerships, will be tracked to assess the competitive landscape of the urinalysis market. This analysis will evaluate market players across various parameters within the broader categories of business and product strategy.
To estimate the market size, both top-down and bottom-up approaches were used. The market breakdown and data triangulation were used to determine the sizes of segments and subsegments.
The four steps involved in estimating the market size are:
Secondary Research
In the secondary research process, various secondary sources, including annual reports, press releases and investor presentations from companies, white papers, certified publications, articles by recognized authors, gold- and silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva), were consulted to identify and collect information for this study.
Primary Research
In the primary research process, interviews with sources from both the supply and demand sides were conducted to gather qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries, as well as preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations across all segments of this industry’s value chain. In-depth interviews were conducted with key industry participants, subject-matter experts, C-level executives at key market players, and industry consultants to obtain and verify critical qualitative and quantitative information and to assess prospects.
Note 1: Other designations include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.
|
COMPANY NAME |
DESIGNATION |
|
Sysmex Corporation |
Sales Manager |
|
Thermo Fisher Scientific, Inc. |
Sales Executive |
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the urinalysis market. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research.
- The revenue generated by leading players operating in the urinalysis market was determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
The research methodology used to estimate the market size includes the following:
Data Triangulation
After determining the overall market size using the process described above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.
Market Definition
Urinalysis is a procedure used to assess the appearance, concentration, and content of urine. It detects and helps manage various disorders, such as urinary tract infections, kidney diseases, diabetes, and other metabolic disorders. The primary urinalysis tests include biochemical and sediment analysis. In this report, we have also discussed pregnancy and fertility tests for urine analysis.
Key Stakeholders
- Manufacturers and Distributors of Urinalysis Products
- Hospitals & Clinics
- Diagnostic Laboratories
- Research Laboratories & Institutes
- Research & Development (R&D) Companies
- Government Associations
- Venture Capitalists and Investors
Report Objectives
- To define, segment, and forecast the urinalysis market by product, test type, application, technology, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
- To study the impact of AI on the market, along with the macroeconomic outlook for each region
Available customizations:
MarketsandMarkets offers the following customizations for this market report.
Country Information
- Additional country-level analysis of the urinalysis market
Company profiles
- Additional five company profiles of players operating in the urinalysis market.
Product Analysis
- Product matrix, which provides a detailed comparison of the product portfolio of each company in the urinalysis market
Get the Full Urinalysis Market Report
Full forecast, segment splits, and company analysis for all Urinalysis Market.
- US Urinalysis Market
- Germany Urinalysis Market
- UK Urinalysis Market
- France Urinalysis Market
- Italy Urinalysis Market
- Spain Urinalysis Market
- Russia Urinalysis Market
- China Urinalysis Market
- Japan Urinalysis Market
- India Urinalysis Market
- Australia Urinalysis Market
- South Korea Urinalysis Market
- Brazil Urinalysis Market
- Mexico Urinalysis Market
- Rest Of Europe Urinalysis Market
- Rest Of Asia Pacific Urinalysis Market
- Rest Of Latin America Urinalysis Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
